Placement learning pathways

Published on 09/04/2015 by admin

Filed under Hematology, Oncology and Palliative Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1511 times

7 Placement learning pathways

The cancer and palliative care placement

This chapter explains the varied roles that individuals, teams and departments have in providing services to patients and family members within the cancer and palliative care specialty. While you are on your practice placement, you will be working with some of these individuals and teams across a wide range of departments. Others may not be available at your local trust.

Although your own school of nursing/university and healthcare trust may organise your placements in different ways, many use the ‘hub and spoke’ model. Whether they do or not, this is a great way of identifying clinical learning opportunities. In addition to learning experiences in the hub placement, there are several spoke placements available as part of the learning experience. There are also potential opportunities to go on insight visits to work with multiprofessional team members, for example the community Macmillan nurse or escorting a patient for treatment in a different department.

These experiences are important to help you understand the role of each professional in the care environment and management of the patient and their family. Being familiar with the range of roles available and how they work in your clinical area can help in your assessment and care planning for a patient.

The ‘hub and spoke’ model in Figure 7.1 is supported by the NMC. It gives you the opportunity to be allocated to one clinical area for a period of time while also having the opportunity to be allocated to a spoke area and short insight visits.

In this model, any area could be either a hub or a spoke placement. Some teams and departments may be accessed by an insight visit. Your placement will most likely be composed of one hub with several planned spoke opportunities and insight visits. Discussing the opportunities available with your mentor is important at the start of the placement.

The length of the placement may depend on the year of study as well as local arrangements between the university and clinical areas. Box 7.1 outlines a theoretical example of what a first year nursing student’s 18-week (‘year-long’) placement might look like. This sample placement demonstrates a wide range of learning opportunities that can stem from a core hub placement. It is important to remember that a cancer patient can be nursed in any clinical environment. Some placements will be much shorter than this, most ranging between 8 and 12 weeks. This is dependent on the school of nursing and your stage of training.

These placement experiences reflect the patient journey and will give you some insight into how teams can complement each other with the work they do to provide holistic patient care.

How each team/specialty works in the practice placement

The following individuals, teams and departments are potential spoke placements or insight visits within a hub placement. Some might be new to you while you may already have worked with others and understand their role.

Health and safety requirements in the departments that may be visited from the hub placement

For students who are not working on a specialist chemotherapy/radiotherapy ward, it is important to understand the precautions necessary if escorting a patient to one of these areas or if you spend a day in one of the departments. If you have attended an induction day for the placement, you may have covered these safety topics and this will be a refresher for you.

Cytotoxic medicines

Handling oral or intravenous cytotoxic drugs is extremely hazardous and this is not to be undertaken by a student nurse. Even if you are completing an oral drug administration round while being observed by a registered nurse, you should NOT handle these drugs. It is the responsibility of a qualified member of the team who has received training in cytotoxic handling.

Although you will not be administering cytotoxic medicines, you will be handling body fluids (urine, faeces, vomit) that may contain degrading by-products of the drug. In addition, if there is a spillage of cytotoxic drugs, you may be at risk if the correct procedures are not followed. The effects of exposure to cytotoxic drugs are irritation of the skin in the short term, the risk of developing a cancer, infertility and embryonic mutation (if exposure occurs while pregnant). However, these effects are very rare and usually occur in individuals who administer intravenous cytotoxic medicines all day, every day, for a number of years. By taking protective measures, the overall risk to your health is minimal.

Cytotoxic drugs are excreted in all body fluids but most of the drug is excreted by the kidneys in urine. The drug usually stays in the body for a number of days, but some drugs are slowly excreted, taking up to 48 days to clear.

While patients are undergoing inpatient intravenous cytotoxic treatment, they will generally be on a fluid balance chart to ensure their fluid balance is maintained. They will therefore be asked to collect their urine in either a disposable urinal or bed pan. The first principle is to dispose of the urinal/bed pan as soon as possible so that the urine left in a bathroom or lavatory can’t be knocked over accidently (as well as for infection risk and hygiene reasons). Ask patients to use the nurse call buzzer when they have finished to ensure swift disposal.

Many cancer wards use absorbent granule sachets added to a bed pan or urinal before patients micturate. This ensures that the body fluid becomes semi-solid on contact and reduces the risk of spillage.

Note: before adding absorbent sachets, you must check whether a urinalysis (dip stick) is required. Some cytotoxics have side effects that damage the bladder lining, and all urine must be checked for the presence of blood to ensure immediate action to prevent severe damage. Also, before adding absorbent sachets, you should check if a specimen is required, such as a mid-stream urine (MSU) specimen. If one is required, take this in the normal way but label the bottle and the specimen request form with a ‘hazardous waste’ sticker before sending to the laboratory.

When you are ready to remove the bed pan/urinal, put on an apron and a pair of gloves and take the bed pan/urinal to the sluice. Once in the sluice, you will need to weigh the bed pan/urinal to attain an accurate volume to record on the fluid chart (making sure you subtract the weight of the bed pan/urinal and the absorbent granules). Then place the bed pan/urinal in the macerator (masher).

As well as body fluids, you may encounter a cytotoxic spillage. This is where a drug has leaked from either the bag or cannula or a urinal/bed pan has been knocked over. In this event, you will need to locate a ‘cytotoxic spillage kit’. This should hold all the necessary equipment to clean up the spillage. As a student, you should not undertake the clean up, but may need to go and collect the spillage kit, so find out on the first day where it is stored. You may need to stay with the spillage, alerting passers by of the hazard.

Extravasation

One of the most common emergencies you may encounter in your placement is extravasation. This is where a drug (in this case, a cytotoxic drug) leaks from the cannula into the surrounding tissues causing damage. If left unattended, this condition can cause permanent damage and may require major plastic surgery to repair tissue damage.

There are many factors that may influence whether a patient experiences an extravasation:

Healthcare professional-related factors

To prevent an extravasation, it is essential that the cannula is secured in a manner so that the entrance can be observed. Many health trusts use guidelines such as the Visual Infusion Phlebitis (VIP) score as a way of monitoring and documenting the status of a cannula. Infusions should be monitored at least every hour, and bolus injections (where the drug is injected into the intravenous line) should be give very slowly through a fast-flowing drip. All intravenous lines should be carefully maintained and free flowing prior to any cytotoxic administration. The antecubital fossa should not be used, and any limb where sensory damage is present should be avoided. In addition, lymhoedematous limbs should be avoided, for example when a woman with breast cancer has had her axilla lymph nodes surgically removed and consequently the arm has become swollen due to the lack of lymphatic return.

If an extravasation is suspected, swift action is required. Cytotoxic drugs are categorised into groups depending on the damage they may cause if they extravasate: neutral, irritant and vesicant. The management of each type of drug that extravasates will be treated differently: either spread and dilute or localise and neutralise. Each department that administers cytotoxic drugs should have a policy for how each drug should be handled in the event of it leaking. Each department will also have an emergency extravasation kit which comprises all equipment needed.

It is important to know where essential equipment is kept, even if you are visiting a clinical area for just 1 day. Being able to locate items quickly is an important part of team working.

Planning insight visits and opportunities as part of the practice placement

As you prepare for this placement, having considered the wide range of teams and services available as part of the cancer and palliative care specialty, review your competency documentation and essential skills clusters and note down the areas that you need to focus on. Considering the spoke opportunities now night be a way of achieving a wide variety of competencies.

This chapter introduced you to a range of individuals and team roles as well as departments within the cancer and palliative care specialty. Don’t worry if you don’t come across them all – you will certainly experience many of them and can then link them to the patient experience.

The next section focuses on the cancer/palliative care placement and identifies specific learning opportunities.